The Legislature website will be unavailable intermittently this Saturday, June 13th from 7AM to 7PM during scheduled server maintenance. We apologize for the inconvenience.
The employer must respond to an employee's depressed cholinesterase levels by:
(1) Taking the actions required in Table 1;
AND
(2) Following any additional occupational health recommendations from the LHCP.
Table 1
Required Responses to an Employee's
Depressed Cholinesterase Levels
When: | Action to be taken: | Methods: | |
An employee's RBC or serum cholinesterase levels fall more than twenty percent below the baseline | Evaluate the employee's workplace and work practices to identify and correct potential sources of pesticide exposure | Review: | |
• | Personal protective equipment (PPE) and its condition | ||
• | Employees' PPE usage | ||
• | General sanitation and decontamination practices and availability of decontamination facilities required by WAC 296-307-13050 | ||
• | Pesticide handling practices | ||
• | Pesticide label requirements | ||
An employee's RBC cholinesterase level falls thirty percent or more from the baseline OR An employee's serum cholinesterase level falls forty percent or more from the baseline | Remove the employee from handling and other work exposures to organophosphate and N-methyl-carbamate pesticides such as thinning and harvesting in recently treated areas AND Evaluate the employee's work practices to identify and correct potential sources of pesticide exposure | • | When available, provide the employee with other duties that do not include handling and other work exposures to organophosphate and N-methyl-carbamate pesticides |
• | Provide medical monitoring and cholinesterase testing as recommended by the LHCP | ||
• | Provide salary and benefits as if employee was continuing pesticide application activities | ||
A removed employee's cholinesterase levels return to twenty percent or less below baseline | The employee may return to handling class I and II organophosphate and N-methyl-carbamate pesticides | Continue periodic cholinesterase monitoring | |